Jacquie Ross | Vice President Investor Relations |
Daniel O'Day | Chairman & Chief Executive Officer |
Johanna Mercier | Chief Commercial Officer |
Merdad Parsey | Chief Medical Officer |
Andrew Dickinson | Chief Financial Officer |
Christi Shaw | Chief Executive Officer, Kite |
Brian Abrahams | RBC Capital Markets |
Phil Nadeau | Cowen and Company |
Louise Pearson | Redburn |
Geoff Meacham | Bank of America |
Michael Yee | Jefferies |
Terence Flynn | Goldman Sachs |
Robyn Karnauskas | Truist |
Matthew Harrison | Morgan Stanley |
Ronny Gal | Bernstein |
Hartaj Singh | Oppenheimer |
Good day and thank you for standing by. Welcome to the Gilead Sciences First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the presentation, there will be a question-and-answer session [Operator Instructions] Please be advised that today's conference may be recorded. [Operator Instructions] I'd now like to hand the conference over to your speaker today, Jacquie Ross, Vice President Investor Relations.